Effects of alprostadil combined with hyperbaric oxygen on hearing recovery and hemorheology in patients with sudden sensorineural hearing loss and analysis of related influencing factors

Feng,Tao; Zhang,Qinqin; Wei,Jiasha; Wang,Xiao; Geng,Yang

doi:10.3892/etm.2022.11167

Effects of alprostadil combined with hyperbaric oxygen on hearing recovery and hemorheology in patients with sudden sensorineural hearing loss and analysis of related influencing factors

Authors:
- Tao Feng
- Qinqin Zhang
- Jiasha Wei
- Xiao Wang
- Yang Geng
View Affiliations

Affiliations: Department of Otolaryngology, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China
Published online on: January 27, 2022 https://doi.org/10.3892/etm.2022.11167
Article Number: 242
Copyright: © Feng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The causes of sudden sensorineural hearing loss (SSNHL) are unclear, and the condition cannot be treated with specific regimens. The present study was designed to explore the effects of alprostadil combined with hyperbaric oxygen (HBO) on hearing recovery and hemorheology in patients with SSNHL, and to analyze factors influencing treatment efficacy. in total, 104 patients with SSNHL were enrolled between January 2015 and July 2018 in a randomized controlled trial. Group A (n=52) received alprostadil treatment and Group B (n=52) were treated with HBO plus alprostadil. Following treatment, the overall recovery rates of tinnitus, aural fullness and vertigo in Group B were significantly higher than those in Group A (P<0.05). Low‑, middle‑ and high‑shear whole blood viscosity and whole blood viscosity in the two groups significantly decreased, and those in Group B were significantly lower than those in Group A (P<0.05). The present results indicated that the combination of alprostadil with HBO can improve the therapeutic effect on SSNHL, reduce blood viscosity and improve coagulation function, thus significantly promoting hearing recovery. Further, SSNHL treatment efficacy was influenced by age, time of onset, hearing threshold, presence or absence of tinnitus, plasma viscosity and serum C‑reactive protein levels. The trial registration number for the present study was: NCT02563872.

View Figures

View References

1	Furuhashi A, Matsuda K, Asahi K and Nakashima T: Sudden deafness: Long-term follow-up and recurrence. Clin Otolaryngol Allied Sci. 27:458–463. 2002.PubMed/NCBI View Article : Google Scholar
2	Research on deafness. Doctoral dissertations. Am Ann Deaf. 147:230–233. 2002.PubMed/NCBI
3	Hirayama M, Shitara T, Okamoto M and Sano H: Idiopathic bilateral sensorineural hearing loss: Its clinical study in cases with rapidly progressed deafness. Acta Otolaryngol Suppl. 534:39–42. 1996.PubMed/NCBI View Article : Google Scholar
4	Qiu L, Zheng X, Xie F, Zhang M, Zhang J, Yuan SB and Zeng GZ: Clinical observation on the different frequency hearing damages in sudden deafness treated by electroacupuncture combined with western medicine comprehensive therapy. World J Acupunct Moxibustion. 22:22–27. 2012.
5	Inagaki T, Cureoglu S, Morita N, Terao K, Sato T, Suzuki M and Paparella MM: Vestibular system changes in sudden deafness with and without vertigo: A human temporal bone study. Otol Neurotol. 33:1151–1155. 2012.PubMed/NCBI View Article : Google Scholar
6	Ersoy Callioglu E, Tuzuner A, Demirci S, Cengiz C and Caylan R: Comparison of simultaneous systemic steroid and hyperbaric oxygen treatment versus only steroid in idiopathic sudden sensorineural hearing loss. Int J Clin Exp Med. 8:9876–9682. 2015.PubMed/NCBI
7	Augustin AJ, Diehm C, Grieger F and Bentz J: Alprostadil infusion in patients with dry age related macular degeneration: A randomized controlled clinical trial. Expert Opin Investig Drugs. 22:803–812. 2013.PubMed/NCBI View Article : Google Scholar
8	Güneysu E, Koçman AE, Özatik O, Ovali C, Can B, Alataş İÖ and Sevin MB: The effects of iloprost and alprostadil on ischemia-reperfusion injury in preventing inflammation, tissue degeneration, and apoptosis in rat skeletal muscle. Turk J Med Sci. 47:1028–1036. 2017.PubMed/NCBI View Article : Google Scholar
9	de Pont AC, de Jonge E and Vroom MB: Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 348:557–560. 2003.PubMed/NCBI View Article : Google Scholar
10	Li J, Shi Q, Wei Q and Han P: Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: A meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials. Aging Male. 18(71)2015.PubMed/NCBI View Article : Google Scholar
11	Wei KU, Liu Y, Jing WU, Wang Q, Tong B and Duan M: Meta-analysis of the clinical efficacy of treatment of sudden deafness using hyperbaric oxygen combined with drug in China. Chin J Otol. 12:93–98. 2014.
12	Arndt S, Laszig R, Aschendorff A, Hassepass F, Beck R and Wesarg T: Cochlear implant treatment of patients with single-sided deafness or asymmetric hearing loss. German version. HNO. 65:586–598. 2017.PubMed/NCBI View Article : Google Scholar : (In German).
13	Weiss D, Böcker AJ, Koopmann M, Savvas E, Borowski M and Rudack C: Predictors of hearing recovery in patients with severe sudden sensorineural hearing loss. J Otolaryngol Head Neck Surg. 46(27)2017.PubMed/NCBI View Article : Google Scholar
14	Zhai S, Ning Y, Guiliang Z, Yuhua Z and He Q: Effect of retreatment on the end-stage sudden deafness. Cell Biochem Biophys. 62:403–406. 2012.PubMed/NCBI View Article : Google Scholar
15	Merchant SN, Durand ML and Adams JC: Sudden deafness: Is it viral? ORL J Otorhinolaryngol Relat Spec. 70:52–62. 2008.PubMed/NCBI View Article : Google Scholar
16	Ban JH, Hong SJ, Lee SY, Lee KC and Kim CG: A clinical analysis of psychogenic hearing loss presenting as sudden deafness. Korean J Otolaryngol Head Neck Surg. 48:572–576. 2005.PubMed/NCBI View Article : Google Scholar
17	Domachevsky L, Keynan Y, Shupak A and Adir Y: Hyperbaric oxygen in the treatment of sudden deafness. Eur Arch Otorhinolaryngol. 264:951–953. 2007.PubMed/NCBI View Article : Google Scholar
18	Kornberg A: Letter: Prostaglandin E1 therapy with alprostadil and risk reduction of early hepatic cellular carcinoma after liver transplantation-authors' reply. Aliment Pharmacol Ther. 43:173–174. 2016.PubMed/NCBI View Article : Google Scholar
19	Liu Y, Sun D, Shao S, Jiang W, Sun Z and Li Z: The effect of hyperbaric oxygen therapy to different degree of hearing loss and types of threshold curve in sudden deafness patients. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 24:890–894. 2010.PubMed/NCBI(In Chinese).
20	Tatar S, Orhan N, Yilmaz CU, Arican N, Ahishali B, Kucuk M, Elmas I, Kaya M and Toklu AS: Hyperbaric oxygen therapy for five days increases blood-brain barrier permeability. Undersea Hyperb Med. 44:345–355. 2017.PubMed/NCBI View Article : Google Scholar
21	Jiang J, Wang S and Tong K: Synergic effect of alprostadil injection and ginaton in treating sudden deafness. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 25:597–599. 2011.PubMed/NCBI(In Chinese).
22	Xin W, Wen HL, Zhao Q and Zhao ZW: Blood dilution, hyperbaric oxygen, anticoagulation treatment for acute carbon monoxide poisoning 115 patients. Chinese Journal of Medicinal Guide. 45–47. 2008.
23	Hernández-Tejedor A, Cabré-Pericas L, Martín-Delgado MC, Leal-Micharet AM and Algora-Weber A: EPIPUSE study group. Evolution and prognosis of long intensive care unit stay patients suffering a deterioration: A multicenter study. J Crit Care. 30:654.e1–e7. 2015.PubMed/NCBI View Article : Google Scholar
24	Ren J and Lu Y: Sudden deafness in the elderly. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 12:257–259. 1998.PubMed/NCBI(In Chinese).
25	Liberman MC: Noise-induced hearing loss: Permanent versus temporary threshold shifts and the effects of hair cell versus neuronal degeneration. Adv Exp Med Biol. 875:1–7. 2016.PubMed/NCBI View Article : Google Scholar
26	Gao D, Shao J, Jin W, Xia X and Qu Y: Correlations of serum cystatin C and hs-CRP with vascular endothelial cell injury in patients with systemic lupus erythematosus. Panminerva Med. 60:151–155. 2018.PubMed/NCBI View Article : Google Scholar